Jan 18, 2022 8:00am EST 22nd Century Launching the First Reduced Nicotine Cigarette Authorized by the FDA That Helps You Smoke Less
Jan 03, 2022 2:23pm EST 22nd Century Group to Participate in Fireside Chat Events with Alliance Global Partners Equity Analyst Aaron Grey and Cowen Equity Analyst Vivien Azer on Wednesday, January 5, 2022
Dec 23, 2021 11:46am EST FDA Authorizes Marketing of 22nd Century Group’s VLN® as a Modified Risk Tobacco Product
Dec 14, 2021 4:05pm EST Aurora and 22nd Century Group License Foundational Biosynthesis IP to Cronos Group
Dec 10, 2021 9:20am EST 22nd Century Ready to Provide Full Commercial Support to New Zealand’s Plan to Reduce Nicotine Content of All Cigarettes
Nov 11, 2021 9:20am EST 22nd Century to Participate in Cowen and Roth Capital Investor Conferences in November 2021
Nov 04, 2021 6:00am EDT 22nd Century Group Reports Business Highlights and Financial Results for the Third Quarter 2021
Oct 20, 2021 9:20am EDT 22nd Century Group to Host Webcast to Provide Business Update and Discuss Third Quarter 2021 Results
